home All News open_in_new Full Article

Galderma startet zwei neue klinische Studien mit Nemolizumab

Dermatologiekonzern - Galderma nimmt zwei neue klinische Studien mit dem Wirkstoff Nemolizumab in Angriff.


today 9 d. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Politics
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 54615808
Add Watch Country

arrow_drop_down